KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Acquisitions (2021 - 2025)

Historic Acquisitions for Hims & Hers Health (HIMS) over the last 3 years, with Q3 2025 value amounting to $116.7 million.

  • Hims & Hers Health's Acquisitions rose 65766.61% to $116.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.8 million, marking a year-over-year increase of 69078.51%. This contributed to the annual value of $15.4 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Hims & Hers Health's Acquisitions is $116.7 million, which was up 65766.61% from $5.1 million recorded in Q1 2025.
  • Hims & Hers Health's Acquisitions' 5-year high stood at $116.7 million during Q3 2025, with a 5-year trough of $5.1 million in Q1 2025.
  • For the 3-year period, Hims & Hers Health's Acquisitions averaged around $45.7 million, with its median value being $30.6 million (2021).
  • Within the past 5 years, the most significant YoY rise in Hims & Hers Health's Acquisitions was 65766.61% (2025), while the steepest drop was 65766.61% (2025).
  • Hims & Hers Health's Acquisitions (Quarter) stood at $45.7 million in 2021, then crashed by 66.32% to $15.4 million in 2024, then soared by 657.67% to $116.7 million in 2025.
  • Its last three reported values are $116.7 million in Q3 2025, $5.1 million for Q1 2025, and $15.4 million during Q3 2024.